SCHEMBL2610674

SCHEMBL2610674

CCc1cccc2ccoc12

nearest known ligand 0.47

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.46
GABRB2 P47870 2/20 0.46
EED O75530 1/20 0.45
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3794977 0.84 EED (0.43) EEDHTR2AHTR2CKCNH2
SCHEMBL3793855 0.81 EED (0.41) EEDHTR2AHTR2CKCNH2
SCHEMBL20354322 0.80 GABRA1 (0.48) GABRA1GABRB2EEDHTR2AHTR2C
SCHEMBL5987069 0.80 EED (0.40) EEDHTR2AHTR2CKCNH2
SCHEMBL957265 0.79 EED (0.45) EEDHTR2AHTR2CKCNH2
SCHEMBL8058485 0.79 EED (0.45) EEDHTR2AHTR2CKCNH2
SCHEMBL17361456 0.79 EED (0.45) EEDHTR2AHTR2CKCNH2
SCHEMBL6679464 0.79 EED (0.45) EEDHTR2AHTR2CKCNH2
SCHEMBL8504222 0.79 EED (0.45) EEDHTR2AHTR2CKCNH2
SCHEMBL31137328 0.79 HTR2A (0.47) EEDHTR2AHTR2CKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121584000-A Composite electrolyte, positive electrode plate and all-solid-state battery 绿能起源科技(江苏)有限公司 2026-02-27 CN claimed
US-4113891-A BENZOFURANS FIRMENICH & CIE (CH) 1978-09-12 US claimed
CN-121584000-A Composite electrolyte, positive electrode plate and all-solid-state battery 绿能起源科技(江苏)有限公司 2026-02-27 CN disclosed
WO-2023098815-A1 AROMATIC COMPOUND, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF 上海栖臻医药科技有限公司 2023-06-08 WO disclosed
US-20230159766-A1 CONDUCTIVE POLYMER COMPOSITION, SUBSTRATE, AND METHOD FOR PRODUCING SUBSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-05-25 US disclosed
US-20230012463-A1 CYCLIC SULFAMIDE COMPOUNDS AND METHODS OF USING SAME ASSEMBLY BIOSCIENCES INC (US) 2023-01-12 US disclosed
US-20220175747-A1 Opioid Receptor Ligands And Methods Of Using And Making Same TREVENA, INC. 2022-06-09 US disclosed
US-11208509-B2 Polymer compound for conductive polymer and method for producing same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-12-28 US disclosed
CN-109503531-B Preparation method of benzofuran compound 东莞理工学院 2021-06-01 CN disclosed
US-10851188-B2 Polymer compound for conductive polymer and method for producing same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-12-01 US disclosed
US-10851113-B2 Heterocyclic inhibitors of monocarboxylate transporters THE SCRIPPS RESEARCH INSTITUTE (US) 2020-12-01 US disclosed
US-4113891-A BENZOFURANS FIRMENICH & CIE (CH) 1978-09-12 US disclosed
US-4085109-A Pyridine sulfur flavoring agents FIRMENICH & CIE (CH) 1978-04-18 US disclosed
US-3989713-A Pyrrylmethylthio flavoring agents FIRMENICH & CIE (CH) 1976-11-02 US disclosed
US-3952026-A FLAVOR ADDITIVE FOR FOODS AND BEVERAGES FIRMENICH & CIE (CH) 1976-04-20 US disclosed
US-3952024-A FLAVOR ADDITIVE FOR FOODS AND BEVERAGES FIRMENICH & CIE (CH) 1976-04-20 US disclosed
US-3943260-A TETRAHYDRO-THIO-PHEN-3-ONES FIRMENICH & CIE (CH) 1976-03-09 US disclosed
US-3931245-A FURYLALKYLTHIOL CARBOXYLATES FIRMENICH & CIE (CH) 1976-01-06 US disclosed
US-3931246-A FURYLALKYL-THIOETHERS FIRMENICH & CIE (CH) 1976-01-06 US disclosed
US-3931166-A FLAVORANTS FIRMENICH & CIE (CH) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220175747-A1 Opioid Receptor Ligands And Methods Of Using And Making Same OPRL1, OPRK1, OPRM1 GABRA1 67/4885GABRB2 117/4885EED 4039/4885
US-10851113-B2 Heterocyclic inhibitors of monocarboxylate transporters SLC16A1, SLC16A3, SLC16A7 GABRA1 1855/4885GABRB2 977/4885EED 3357/4885
US-20230012463-A1 CYCLIC SULFAMIDE COMPOUNDS AND METHODS OF USING SAME HCCS, HAVCR2, SLC10A1 GABRA1 1735/4885GABRB2 784/4885EED 4363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.